WebOBIZUR injection will be prepared and administered by a qualified healthcare professional who is experienced in the care of patients with haemophilia. Your doctor will calculate … WebProduct: Prescribing Information: Medication Guide: Instructions For Use: Patient Information: ACTOPLUSMET: ACTOPLUSMET (ENG-USA)---ACTOPLUSMET XR (ENG-USA)
OBIZUR HEMATOLOGY US Site - Takeda Pharmaceutical Company
Web7 apr 2024 · If you are interested in ordering from Takeda's product offerings, please contact Customer Care at 1-800-423-2090 or email us at [email protected]. … WebTakeda Canada Inc. 22, rue Adelaide Ouest, bureau 3800 Toronto (Ontario) M5H 4E3 Date de l’autorisation initiale : 2015-10-14 Date de révision : 2024-03-09 Numéro de contrôle de la présentation : 268812 OBIZURMD est une marque de commerce déposée de Baxalta Incorporated. TAKEDAMC est une marque de commerce de Takeda Pharmaceutical ... renata suša sdp
Post-Marketing Non-Interventional Safety Evaluation of Obizur …
Web20 nov 2015 · This study is a multi-center, uncontrolled, open-label, non-interventional post-marketing safety surveillance study to describe the use of Obizur in patients with acquired hemophilia A (AHA), and secondarily, where data are available, to describe the hemostatic effectiveness and immunogenicity of Obizur. Web17 set 2024 · Obizur is a medicine used for the treatment of bleeding episodes in adults with acquired haemophilia, a bleeding disorder caused by the spontaneous … Web13. Use OBIZUR immediately and within 3 hours after reconstitution when stored at room temperature. Administration. For intravenous injection only. • Inspect the reconstituted OBIZUR solution for particulate matter and discolouration prior to administration. The solution should be clear and colourless in appearance. renata sr 626 sw